跳至主要内容
临床试验/EUCTR2017-003362-27-NL
EUCTR2017-003362-27-NL进行中(未招募)1 期

Ketanserin effects on Peripheral Temperature and Lactate - KoPTa

OLVG0 个研究点目标入组 120 人开始时间: 2017年10月24日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • -DeltaTemperature greater than 6.0 °C.
  • -Age 18 years or older
  • -Admitted to the ICU for any reason
  • -Written informed consent from the patient or legal representative
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 40
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 80

排除标准

  • -Pregnancy
  • -No possibility to obtain informed consent
  • -QTc above 550 msec,
  • -Arrhythmias, including bradycardia defined as a heart rate below 50/min; 2nd and 3rd degree AV block; ventricular tachycardia
  • -Blood Potassium level < 3.5 mmol/l
  • -Blood Magnesium level <0.5 mmol/l
  • -Allergy for ketanserin
  • -DeltaTemperature less than 6°C.
  • -Patients undergoing therapeutic hypothermia
  • - Patients admitted after cardiac arrest
  • - Patients admitted after cardiac surgery

研究者

发起方
OLVG

相似试验

The effects of the medicine Ketanserin on Peripheral... | 临床试验